Member Info for PhilGekko

Welcome dogdays... in my opinion possibly the best time to join. Let's hope for a couple of great webinars next week.

With an Associate Professor from Harvard Medical School.

https://zoom.us/webinar/register/5416208262552/WN_LHkgZqIzS4OUS6Oefu87mA

When Blautix results came in (and they were not bad in my non-expert opinion, as I have stated here a few times) we tanked approx. 50% (fifty percent)!!!. When an RNS arrives stating that there will be additional data presented at a conference (and presumably these are positive findings otherwise why would the company bother?) followed by and analyst Q&A - we bounce spectacularly 1% - interesting.

Clearly I am a holder, please do your own due diligence before investing and don't trust ANYONE on these boards, too many people with various agendas here.

Interesting, I had a gut feeling we would hear about Blautix again but the fact there will be some additional data and involve analyst q&a certainly sounds very positive to me. This company has several really decent shots on target imho. Let's hope for a nice lift at 8am.

Same applies for great companies. If our trials come through for us and the company ends up prolonging/saving lives - whichever company shorts it will burn their money to a crisp.

Thanks Nightmare... Great news!

Do 4D Pharma's CEO and CSO have $2 million ( I believe that's what they recently invested @ 110p, is that right?) between them to just invest into a company to appease PIs/IIs - unless they thought this was a safe investment?

That is the questions. These are also 2 guys who have access to the information about current trials and commercial discussions @ 4D.

So difficult to eliminate all the white noise (ramping/deramping) on these boards - the question above is what I think it all boils down to. Thoughts?

Don't understand this selling... someone is offloading I think, but why? We have catalysts coming up soon and company is looking good on several fronts imho. What are we missing here?

Many thanks Moneymunch, appreciated. Seems like a decent risk/reward ratio to me but need to do more DD on SFX-01...cheers

hello everyone, relatively new to Evgen... reading posts here seems like we are expecting results any day now...? Are they overdue (late) or have they given themselves a fairly broad timeline (i.e. Q2)? Thanks!

We have several catalysts coming along, CEO and CSO invested significant chunk of their cash recently, Merck also, and we drop another 10% ? Does that sound crazy to anyone here?

This is rather strange... any ideas what is going on? I can't see any huge selling going on... can anyone?

Steve1981... thanknyou for the advice. Let's focus on 4D Pharma on this board.

Hopefully this gets picked up by the mainstream media also and SNG receive some proper exposure. Let's hope for another push after the 9am webinar.

Thanks Tornado!

Sangi - thanks for the tip, just looking at C4XD. Incredible they are still sitting at £90mn mcap.

In terms of 4D... well, we should see a few people jump on board now I think

Hi Sangi, yes they all seem to be geared towards drug discovery/pre-clinical... which for us small investors looks like a long-term thing but IIs love it as it gives them a stronger long-term investment case. Anyhow nice to see company feeling bullish (especially after that RNS today)

https://www.linkedin.com/posts/4d-pharma-plc_join-us-activity-6788752027099897856-XgOJ

Many thanks Sangi - really good to hear even though i would love them to get that first approval, I think it would definitely have a positive effect on us as well.
Any catalyst, but especially oncology trials if positive, would be huge for us. If we somehow get to be the first ones to take a drug to market (through Merck possibly as a combination therapy with Keytruda) that would be mind-blowing. We are still some way behind but if Seres keep messing things up who knows..

Sangi - haven't been thoroughly through Seres' flop (i.e. reasons for it etc.) - is there anything there we should be wary of? We are all still looking for that first approval, thanks